Olicon sells TAP program

Article

PACS vendor Olicon Imaging Systems of Aliso Viejo, CA, has divested its teleradiology archiving program (TAP) and microfilm division to F.Y.I., a document and information outsourcing solutions company. Terms of the deal were not immediately released.

PACS vendor Olicon Imaging Systems of Aliso Viejo, CA, has divested its teleradiology archiving program (TAP) and microfilm division to F.Y.I., a document and information outsourcing solutions company. Terms of the deal were not immediately released. Although Olicon officials were not available to comment on the sale, the move appears to be in line with their decision to focus on OEM distribution opportunities with healthcare information systems companies, particularly with partner Shared Medical Systems of Malvern, PA (SCAN 11/11/98).

The TAP program allows healthcare institutions to store their radiology films at off-site warehouses in Louisville, KY, and Ontario, CA. When needed, the films are scanned via a film digitizer and transmitted electronically to the requesting site. Dallas-based F.Y.I. will call its new division F.Y.I. Radiology Archiving and Imaging Services.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.